Merakris Therapeutics, Inc. Email Format

Biotechnology ResearchNorth Carolina, United States11-50 Employees

Merakris Therapeutics, Inc. operates in the biotechnology research sector with a focus on regenerative medicine. The company develops and markets biologic therapies derived from stem cells intended to restore balance to damaged tissue and improve patient outcomes while potentially reducing the need for repeated treatments. Based in Research Triangle Park, North Carolina, it concentrates on wound-healing therapies and related regenerative products, and it seeks to educate clinicians and patients about regenerative medicine as an alternative to more invasive options. The organization maintains a small to mid-sized team engaged in research, development, and regulatory activities.

Among its activities, Merakris Therapeutics is advancing MTX-001 as a treatment for venous leg ulcers and has pursued an Investigational New Drug application with the U.S. Food and Drug Administration. In June 2026, the company expanded access to its Dermacyte AC Matrix Amniotic Membrane Allograft through a Veterans Affairs contract.

Get verified Merakris Therapeutics, Inc. emails free

Company overview Employee directory